Antidepressant treatment of fibromyalgia. A meta-analysis and review

Psychosomatics

Volumn 41, Issue 2, 2000, Pages 104-113

  Arnold, Lesley M ^a,b   Keck, Paul E ^a,b   Welge, Jeffrey A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CYCLOBENZAPRINE; DOSULEPIN; FLUOXETINE; IBUPROFEN; MAPROTILINE; NAPROXEN; S ADENOSYLMETHIONINE; TEMAZEPAM;

CLINICAL TRIAL; DRUG EFFICACY; FIBROMYALGIA; HUMAN; META ANALYSIS; MULTICENTER STUDY; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PREDICTION; REVIEW; SAMPLING; SLEEP; TREATMENT OUTCOME;

EID: 0034117292     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.41.2.104     Document Type: Review

References (72)

1. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multienter Criteria Committee. Arthritis Rheum 1990; 33:160-172
2. Hudson JI, Pope HG, Jr: The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am 1996; 22:285-303
3. Wolfe F, Ross K, Anderson J, et al: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38:19-28
4. Simms RW: Controlled trials of therapy in fibromyalgia syndrome. Baillieres Clin Rheumatol 1994; 8:917-934
5. Goldenberg DL: A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome. J Rheumatol 1989; 16[Suppl 19]:137-139
6. Godfrey RG: A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med 1996; 156:1047-1052
7. Moldofsky H, Scarisbrick P, England R, et al: Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975; 37:341-345
8. Moldofsky H, Scarisbrick P: Induction of neurasthenic musculo-skeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1975; 38:35-44
9. Sicuteri F: Headache as a possible expression of deficiency of brain 5-hydroxytryptamine (central denervation sensitivity). Psychosom Med 1972; 12:69-72
10. Gruber AJ, Hudson JI, Pope HG, Jr: The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine: fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am 1996; 19:351-369
11. Buchwald D, Garrity D: Comparison of patients with chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivities. Arch Intern Med 1994; 154:2049-2053
12. Buchwald D, Goldenberg DL, Sullivan JL, et al: The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia. Arthritis Rheum 1987; 20:1132-1136
13. Goldenberg DL: Fibromyalgia and other chronic fatigue syndromes: is there evidence for chronic viral disease? Semin Arthritis Rheum 1988; 18:111-120
14. Yunus MB, Masi AT, Aldag JC: A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol 1989; 16:62-71
15. Cassidy WL, Flanagan NB, Spellman M, et al: Clinical observations in manic-depression illness: a quantitative study on one hundred manic-depressive patients and fifty medically sick controls. JAMA 1957; 153:1535-1546
16. Mezzih JE, Raab ES: Depressive symptomatology across the Americas. Arch Gen Psychiatry 1980; 37:818-823
17. Stoeckle JD, Davidson GE: Bodily complaints and other symptoms of depressive reaction. JAMA 1962; 180:134-139
18. Burckhardt CS, Wiens AN, O'Reilly CA, et al: Psychological status of women with fibromyalgia (FMS). Arthritis Rheum 1990; 33(suppl):S136
19. Goldenberg SL: Psychological studies in fibrositis. Am J Med 1986; 81(suppl 3A):67-70
20. Hudson JI Goldenberg DL, Pope HG, Jr, et al: Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92:363-367
21. Hudson JI, Hudson MS, Pliner LF, et al: Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985; 142:441-446
22. Tariot PN, Yocum D, Kalin NH: Psychiatric disorders in fibromyalgia. Am J Psychiatry 1986; 143:813-814
23. Walker EA, Keegan D, Gardner G, et al: Psychosocial factors in fibromyalgia and rheumatoid arthritis, I: psychiatric diagnoses and functional disability. Psychosom Med 1997; 59:565-571
24. Ahles TA, Khan SA, Yunus MB, et al: Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry 1991; 148:1721-1726
25. Kirmayer JL, Robbins JM, Kapusta MA: Somatization and depression in fibromyalgia syndrome. Am J Psychiatry 1985; 145:950-954
26. Alfici S, Sigal M, Landau M: Primary fibromyalgia syndrome - a variant of depressive disorder? Psychother Psychosom 1989; 51:156-161
27. Bouckons AJ: Chronic pain: neuropsychopharmacology and adjunctive psychiatric treatment, in Textbook of Consultation-Liaison Psychiatry. Edited by Rundell JR, Wise MG. Washington, DC, American Psychiatric Press, 1996, pp 1006-1037
28. Frank RG, Kashani JH, Parker JC, et al: Antidepressant analgesia in rheumatoid arthritis. J Rheumatol 1988; 15:1632-1638
29. Alarcon GS, Bradley LA: Advances in the treatment of fibromyalgia: current status and future directions. Am J Med Sci 1998; 315:397-404
30. Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29:1371-1377
31. Carette S, McCain GA, Bell DA, et al: Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study. Arthritis Rheum 1986; 29:655-659
32. Bibolotti E, Borghi C, Pasculli E, et al: The management of fibrositis: a double-blind comparison of maprotiline (Ludiomil), chlorimipramine, and placebo. J Clin Trials 1986; 23:269-280
33. Caruso I, Puttini PCS, Boccassini L, et al: Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1987; 15:154-159
34. Scudds RA, McCain GA, Rollman GB, et al: Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989; 16[Suppl 19]:98-103
35. Hench PK, Cohen R, Mitler MM: Fibromyalgia: effects of temazepam, amitriptyline and placebo on pain and sleep. Sleep Res 1989; 18:335
36. Jaeschke R, Adachi J, Guyatt G, et al: Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 1991; 18:447-451
37. Carette S, Bell MJ, Reynolds WJ, et al: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum 1994; 37:32-40
38. Carette S, Oakson G, Guimont C, et al: Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 1995; 38:1211-1217
39. Goldenberg DL, Mayskiy M, Mossey C, et al: A randomized double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852-1859
40. Bennett RM, Gatter RA, Campbell SM, et al: A comparison of cyclobenzaprine and placebo in the management of fibrositis. Arthritis Rheum 1988; 31:1535-1542
41. Quimby LG, Gratwick GM, Whitney CD, et al: A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol 1989; 16(suppl 19):140-143
42. Reynolds WJ, Moldofsky H, Saskin P, et al. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991; 18:452-454
43. Simms RW, Felson DT, Goldenberg DL: Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol 1991; 18:1558-1563
44. Cantini F, Bellandi F, Niccoli L, et al: Fluoxetine associata a ciclobenzaprina nel trattamentao della fibromialgia. Minerva Med 1994; 85:97-100
45. Santandrea S, Montrone F, Sarzi-Puttini P, et al: A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res 1993; 21:74-80
46. Smythe HA: Fibrositis and other diffuse musculoskeletal syndromes, in Textbook of Rheumatology, 1st Edition. Edited by Kelley WN, Harris ED Jr, Ruddy S, et al. Philadelphia, Saunders, 1981, pp 485-493
47. Campbell SM, Clark S, Tindall EA, et al: Clinical characteristics of fibrositis, I: a "blinded" controlled study of symptoms and tender points. Arthritis Rheum 1983; 26:817-824
48. Cedarbaum JM, Schleifer LS: Drugs for Parkinson's disease, spasticity, and acute muscle spasms, in The Pharmacological Basis of Therapeutics. Edited by Gilman AG, Rail TW, Nies AM, et al. Elmsford, NY, Persimmon, 1990, pp 463-484
49. Harsch HH. Mania in two patients following cyclobenzaprine. Psychosomatics 1984; 25:791-793
50. Barnes CD, Fung SJ, Gintautus J: Brain stem noradrenergic system depression by cyclobenzaprine. Neuropharmacology 1980; 19:221-224
51. Share NN, McFarlane CS: Cyclobenzaprine: a novel centrally acting skeletal muscle relaxant. Neuropharmacology 1975; 14:675-684
52. Kobayashi H, Hasegawa Y, One H: Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. Eur J Pharmacol 1996; 311:29-35
53. Lang IM: Cyclobenzaprine effects on locus coeruleus cells in tissue slice. Neuropharmacology 1983; 22:249-252
54. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd Edition. Hillsdale, NJ, Erlbaum, 1988
55. Kalaian HA, Raudenbush SW: A multivariate mixed linear model for meta-analysis. Psychological Methods 1996; 1:227-235
56. Matt GE, Cook TD: Threats to the validity of research syntheses, in The Handbook of Research Synthesis. Edited by Cooper H, Hedges LV. New York, Russell Sage Foundation, 1988
57. Yunus M, Masi AT, Calabro JJ, et al: Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11:151-172
58. Smythe HA, Moldofsky H: Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 1997; 28:928-931
59. Wolfe F, Cathey MA, Hawley DJ: A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994; 23:255-259
60. Nκrregard J, Volkmann H, Danneskiold-Samsde B: A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 1995; 61:445-449
61. Ekselius L, VonKnorring L, Eberhard G: A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression. Int Clin Psychopharmacol 1997; 12:323-331
62. Russell IJ, Fletcher EM, Michalek JE, et al: Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. Arthritis Rheum 1991; 34:552-560
63. Tavoni A, Vitali C, Bombardieri S, et al: Evaluation of S-adenosylmethionine in primary fibromyalgia. Am J Med 1987; 83[Suppl 5A]:107-110
64. Jacobsen S, Danneskiold-SamsKe B, Andersen RB: Oral S-adenosylmethionine in primary fibromyalgia: double-blind clinical evaluation. Scan J Rheumatol 1991; 20:294-302
65. Rickels K, Chung HR, Csanalosi IB, et al: Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. Arch Gen Psychiatry 1987; 44:862-866
66. Russell IJ, Vipraio GA, Morgan WW, et al: Is there a metabolic basis for the fibrositis syndrome? Am J Med 1986; 81(suppl 3A):50-54
67. Lipinski JF, Cohen BM, Frankenburg F, et al: Open trial of S-adenosylmethlonine for treatment of depression. Am J Psychiatry 1984; 141:448-450
68. Dwight MM, Arnold LM, O'Brien H, et al: An open clinical trial of venlafaxine in fibromyalgia. Psychosomatics 1998; 39:14-17
69. Tollefson GD, Rosenbaum JF: Selective serotonin reuptake inhibitors, in Textbook of Psychopharmacology, 2nd Edition. Edited by Schatzberg AF, Nemeroff CB. Washington, DC, American Psychiatric Press, 1998, pp 219-237
70. Burke MJ, Preskorn SH: Short-term treatment of mood disorders with standard antidepressants, in Psychopharmacology: the Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven, 1995, pp 1053-1066
71. Potter WZ, Manji HK, Rudorfer MV: Tricyclics and tetracyclics, in Textbook of Psychopharmacology, 2nd Edition. Edited by Schatzberg AF, Nemeroff CB. Washington, DC, American Psychiatric Press, 1998, pp 199-218
72. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for the DSM-IV Axis I Disorders: Patient Edition (SICD-I/P, Version 2.0). New York, Biometrics Research Department, New York State Psychiatric Institute, 1995